Clinical Trial Update: Talc Pleurodesis in Patients With Recurrent Malignant Pleural Effusion [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating talc pleurodesis for recurrent malignant pleural effusion has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Effusion

Drugs mentioned

• Talc (intracavitary talc) (talc)

Snippet

Sponsor: University of Sao Paulo | Conditions: Recurrent Malignant Pleural Effusion. | Phase 4 | Status: COMPLETED